Pharmaceutical / Drug Definition :
Binds to nuclear receptors in responsive tissues (such as female genital organs, breasts, and pituitary gland), enhancing DNA, RNA, and protein synthesis. In androgen-dependent prostate cancer, competes for androgen receptor sites, inhibiting androgen activity. Also decreases pituitary release of follicle-stimulating hormone and luteinizing hormone.
FDA Label Requirements and Exceptions
FDA Import Information
Estradiol Cypionate (Estradiol Cypionate Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Estradiol Cypionate (Estradiol Cypionate Suppliers)
- Processors Estradiol Cypionate
- Repackers Estradiol Cypionate
- Relabelers Estradiol Cypionate
- Exporters Estradiol Cypionate
- Importers Estradiol Cypionate
For more information about Estradiol Cypionate, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.